Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer [Phase 2]
Phase 2 trial update evaluating apatinib with paclitaxel and carboplatin as neoadjuvant therapy for locally advanced triple-negative breast …
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer [Phase 2]
Phase 2 trial evaluating capecitabine plus bendamustine in women with pretreated locally advanced or metastatic HER2-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement [Phase 3]
Phase 3 trial evaluating zoledronic acid for bone involvement in metastatic breast cancer, metastatic prostate cancer, or multiple myeloma; …
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel [Phase 2]
Phase 2 trial evaluating minocycline hydrochloride to reduce chemotherapy-induced peripheral neuropathy and acute pain in breast cancer pati…
-
CLINICAL_TRIALS trial_result · 2018-11-06Clinical Trial Update: The LightPath® and 68Ga-RM2 in Breast Cancer Study [Phase 3]
Phase 3 clinical trial update for LightPath® and 68Ga-RM2 in breast cancer (Breast Cancer).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-06Clinical Trial Update: Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer [Phase 3]
A Phase 3 trial comparing filgrastim plus chemotherapy versus filgrastim alone in women undergoing peripheral stem cell transplantation for …
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Multi-catheter High Dose Rate (HDR) Breast Brachytherapy [Phase 2]
Phase 2 clinical trial update for multi-catheter HDR breast brachytherapy in breast cancer; study terminated with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients [Phase 2]
Phase 2 trial comparing trastuzumab to lapatinib as neoadjuvant therapy in HER2-positive breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating pembrolizumab with a monoclonal antibody therapy in advanced cancers; study TERMINATED with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2018-11-01Clinical Trial Update: Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention [NA]
Completed clinical trial evaluating nutritional supplements and hormonal manipulations for breast cancer prevention; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP） [Phase 3]
A Phase 3 clinical trial evaluating exemestane tablets with ovarian function suppression in premenopausal breast cancer patients carrying CY…
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: A Study of MK-2206 in Combination With Trastuzumab and Lapatinib for the Treatment of HER2+ Solid Tumors (MK-2206-015) [Phase 1]
Phase 1 study evaluating MK-2206 in combination with trastuzumab and lapatinib for HER2-positive solid tumors; the trial was terminated and …
-
CLINICAL_TRIALS trial_result · 2018-10-30Clinical Trial Update: Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca. [Phase 3]
Phase 3 trial comparing Myl1401O + Taxane versus Herceptin + Taxane for first-line metastatic breast cancer; completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: Pilot Study of an Intimacy Enhancement Intervention for Couples Facing Breast Cancer [NA]
Pilot study completed for an intimacy enhancement intervention for couples coping with breast cancer; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: A Study to Compare the Effect of SB3 and Herceptin® in Women With HER2 Positive Breast Cancer [Phase 3]
Phase 3 trial comparing SB3 biosimilar to Herceptin in HER2-positive breast cancer; completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body. [Phase 2]
Phase II trial assessing safety and effects of HSP-130 injected under the skin in women with non-metastatic breast cancer; study completed w…
-
CLINICAL_TRIALS withdrawal · 2018-10-22Clinical Trial Update: Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer [Phase 3]
Phase 3 trial investigating enzalutamide with paclitaxel vs placebo with paclitaxel in advanced triple-negative breast cancer was withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer [Phase 1]
Phase 1 study evaluating the proper dosage of lovastatin and docetaxel in cancer patients; the trial has been terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2018-10-18Clinical Trial Update: Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide [Phase 4]
Phase 4 multicenter trial evaluating pharmacokinetic-guided docetaxel in combination with cyclophosphamide for breast cancer; study complete…
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer [Phase 1]
Phase 1 trial evaluating AZD2014 in combination with fulvestrant in ER-positive advanced/metastatic breast cancer has completed with results…
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer [NA]
Pilot study evaluating estradiol followed by exemestane in hormone receptor-positive metastatic breast cancer; trial completed with posted r…
-
FDA approval · 2018-10-16FDA Approved: TALZENNA — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved TALZENNA (talazoparib) as a single-agent treatment for adults with deleterious or suspected deleterious germline BRCA-mutated, …
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Scalp Cooling to Prevent Chemo-induced Hair Loss [NA]
Clinical trial update regarding scalp cooling to prevent chemotherapy-induced hair loss in breast cancer patients; status and results detail…
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy [Phase 2]
Phase 2 trial comparing capecitabine to vinorelbine in high-risk breast cancer with pathologic residual tumors after preoperative chemothera…
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer [Phase 3]
A Phase 3 randomized trial evaluating postmastectomy hypofractionation radiotherapy in high-risk breast cancer has completed.